FDA NDC Directory · JSON-LD · Markdown

Ondansetron

NDC 71205-713 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerProficient Rx LP
Marketing categoryAbbreviated NDA (generic) · App ANDA090469
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsONDANSETRON (8 mg/1)
Marketing started20100412
Package count5

External sources

Source: openFDA. Public-domain (CC0).